Click to copy
Click to copy
Related topics

Intellipharmaceutics: Fiscal 2Q Earnings Snapshot

July 11, 2019

TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Wednesday reported a loss of $2.1 million in its fiscal second quarter.

The Toronto-based company said it had a loss of 10 cents per share.

The extended-release drug developer posted revenue of $1.2 million in the period.

The company’s shares closed at 21 cents. A year ago, they were trading at $4.80.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF

All contents © copyright 2019 The Associated Press. All rights reserved.